adamantane has been researched along with citrulline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernad, N; Burgaud, BG; Horwell, DC; Lewthwaite, RA; Martinez, J; Pritchard, MC | 1 |
Cenarruzabeitia, E; Del Río, J; García-López, MT; González-Muñiz, R; Latorre, M; Martín-Martínez, M | 1 |
Bellamine, A; Jacob, RF; Jacoby, A; Kubant, R; Malinski, T; Mason, RP; Mizuno, Y; Walter, MF | 1 |
3 other study(ies) available for adamantane and citrulline
Article | Year |
---|---|
The design and synthesis of the high efficacy, non-peptide CCK1 receptor agonist PD170292.
Topics: Adamantane; Animals; Citrulline; Peptoids; Rats; Receptors, Cholecystokinin | 2000 |
Effects of the incorporation of IBTM beta-turn mimetics into the dipeptoid CCK(1) receptor agonist PD 170292.
Topics: Adamantane; Animals; Cerebral Cortex; Citrulline; Molecular Mimicry; Pancreas; Rats; Receptors, Cholecystokinin | 2002 |
Effect of enhanced glycemic control with saxagliptin on endothelial nitric oxide release and CD40 levels in obese rats.
Topics: Adamantane; Animals; Aorta; Blood Glucose; CD40 Antigens; Cholesterol; Citrulline; Dipeptides; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Nitric Oxide Synthase Type III; Obesity; Rats; Rats, Zucker; Triglycerides | 2011 |